🎉 M&A multiples are live!
Check it out!

Kolmar Korea Valuation Multiples

Discover revenue and EBITDA valuation multiples for Kolmar Korea and similar public comparables like Sarantis Group, Live Verdure, and Lavipharm.

Kolmar Korea Overview

About Kolmar Korea

Kolmar Korea Co Ltd is a Korea-based company which is mainly engaged in manufacture and sale of cosmetics. It offers various products such as skin care, makeup, hair care, body care and others. The firm is also involved in development and production of pharmaceutical products and quasi-drugs including general medicines, specialized medicines, bioequivalence medicines and others.


Founded

2012

HQ

South Korea
Employees

n/a

Website

kolmar.co.kr

Sectors

Health & Beauty

Financials

LTM Revenue $1.7B

LTM EBITDA $205M

EV

$1.8B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Kolmar Korea Financials

Kolmar Korea has a last 12-month revenue of $1.7B and a last 12-month EBITDA of $205M.

In the most recent fiscal year, Kolmar Korea achieved revenue of $1.7B and an EBITDA of $190M.

Kolmar Korea expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Kolmar Korea valuation multiples based on analyst estimates

Kolmar Korea P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $1.5B $1.7B XXX XXX XXX
Gross Profit $319M $394M XXX XXX XXX
Gross Margin 22% 24% XXX XXX XXX
EBITDA $118M $190M XXX XXX XXX
EBITDA Margin 8% 11% XXX XXX XXX
Net Profit -$15.0M $3.5M XXX XXX XXX
Net Margin -1% 0% XXX XXX XXX
Net Debt $540M $590M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Kolmar Korea Stock Performance

As of April 15, 2025, Kolmar Korea's stock price is KRW 73000 (or $50).

Kolmar Korea has current market cap of KRW 1.72T (or $1.2B), and EV of KRW 2.66T (or $1.8B).

See Kolmar Korea trading valuation data

Kolmar Korea Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.8B $1.2B XXX XXX XXX XXX $3.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Kolmar Korea Valuation Multiples

As of April 15, 2025, Kolmar Korea has market cap of $1.2B and EV of $1.8B.

Kolmar Korea's trades at 1.1x LTM EV/Revenue multiple, and 8.9x LTM EBITDA.

Analysts estimate Kolmar Korea's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Kolmar Korea and 10K+ public comps

Kolmar Korea Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.8B XXX XXX XXX
EV/Revenue 1.1x XXX XXX XXX
EV/EBITDA 9.6x XXX XXX XXX
P/E 19.1x XXX XXX XXX
P/E/Growth 0.5x XXX XXX XXX
EV/FCF -59.1x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Kolmar Korea Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Kolmar Korea Valuation Multiples

Kolmar Korea's NTM/LTM revenue growth is 11%

Kolmar Korea's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Kolmar Korea's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Kolmar Korea's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Kolmar Korea and other 10K+ public comps

Kolmar Korea Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 14% XXX XXX XXX XXX
EBITDA Margin 11% XXX XXX XXX XXX
EBITDA Growth 61% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 23% XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue 8% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue 1% XXX XXX XXX XXX
Opex to Revenue 21% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Kolmar Korea Public Comps

See public comps and valuation multiples for Health & Beauty comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Acme United XXX XXX XXX XXX XXX XXX
EZZ Life Science XXX XXX XXX XXX XXX XXX
Live Verdure XXX XXX XXX XXX XXX XXX
Lavipharm XXX XXX XXX XXX XXX XXX
Sarantis Group XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Kolmar Korea M&A and Investment Activity

Kolmar Korea acquired  XXX companies to date.

Last acquisition by Kolmar Korea was  XXXXXXXX, XXXXX XXXXX XXXXXX . Kolmar Korea acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Kolmar Korea

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Kolmar Korea

When was Kolmar Korea founded? Kolmar Korea was founded in 2012.
Where is Kolmar Korea headquartered? Kolmar Korea is headquartered in South Korea.
Who is the CEO of Kolmar Korea? Kolmar Korea's CEO is Mr. Hyun-kyu Choi.
Is Kolmar Korea publicy listed? Yes, Kolmar Korea is a public company listed on KRX.
What is the stock symbol of Kolmar Korea? Kolmar Korea trades under 161890 ticker.
When did Kolmar Korea go public? Kolmar Korea went public in 2012.
Who are competitors of Kolmar Korea? Similar companies to Kolmar Korea include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm.
What is the current market cap of Kolmar Korea? Kolmar Korea's current market cap is $1.2B
What is the current revenue of Kolmar Korea? Kolmar Korea's last 12-month revenue is $1.7B.
What is the current EBITDA of Kolmar Korea? Kolmar Korea's last 12-month EBITDA is $205M.
What is the current EV/Revenue multiple of Kolmar Korea? Current revenue multiple of Kolmar Korea is 1.1x.
What is the current EV/EBITDA multiple of Kolmar Korea? Current EBITDA multiple of Kolmar Korea is 8.9x.
What is the current revenue growth of Kolmar Korea? Kolmar Korea revenue growth between 2023 and 2024 was 14%.
Is Kolmar Korea profitable? Yes, Kolmar Korea is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.